The Effect of Digital Storytelling on Nursing Students' Compliance
The Effect of Digital Storytelling on Nursing Students' Compliance With Isolation Precautions and Their Knowledge Levels: A Randomized Controlled Trial
Tutkimuksen yleiskatsaus
Tila
Interventio / Hoito
Opintotyyppi
Ilmoittautuminen (Todellinen)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
-
Trabzon, Turkki
- Şule BIYIK BAYRAM
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- Being voluntary
- Having access to the Internet
Exclusion Criteria:
- Not attending the digital storytelling activity (intervention)
- Not taking the posttest
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Muut
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Ei mitään (avoin tarra)
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Kokeellinen: Digital Story Group
Digital Story Group: One of the researchers gave the experimental group participants a 15-minute briefing on how to perform digital storytelling.
She also told them not to talk to the control group participants about the content of the briefing.
She created a Pixton account (https://edu.pixton.com/educators/)
and a class named "Isolation."
She sent the link (https://join.pixton.com/x5xb6) to the experimental group participants.
She asked them to click on the link and make stories out of their knowledge of isolation in four weeks.
|
Digital story
|
|
Ei väliintuloa: Control Group
Control group participants did not go through any training in isolation.
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Distribution of students according to descriptive characteristics.
Aikaikkuna: 1 month
|
The 11-item demographic characteristics questionnaire was based on a literature review conducted by the researchers (Özden and Özveren, 2016; Orabi, 2017; Sarier and Kurşun, 2020). The experimental and control group participants had a mean age of 22.57±2.28 and 21.79±0.80, respectively. The experimental group consisted of 56 women and ten men. The control group consisted of 38 women and six men |
1 month
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
The difference between the pre, post and follow-up knowledge scores of the control and experimental group students
Aikaikkuna: 1 month
|
The Isolation Knowledge Test (IKT) was based on a literature review conducted by the researchers (Erden et al., 2015, Doğanay et al., 2013, Karabay et al., 2018). Three experts in nursing fundamentals were consulted to develop the test. The draft test consisted of 40 statements. A pilot study was conducted to check for the intelligibility and relevance of the statements and to calculate item difficulty and item discrimination indices. was a significant difference between pretest and posttest IKT scores in the experimental group (p=0.01). There was also a significant difference between posttest and follow-up IKT scores in the experimental group (p=0.01). The experimental group had significantly higher follow-up IKT scores than pretest scores. |
1 month
|
|
The difference between the control and experimental group scores according to the total and sub-dimensions of the scale
Aikaikkuna: 2 months
|
The Scale of Compliance with Isolation Precautions (SCIP) was developed by Tayran and Ulupınar (2011). The scale consists of 18 items scored on a five-point Likert-type scale ("1 = Strongly disagree," "2 = Disagree," "3 = Neither agree nor disagree," "4 = Agree," "5 = Strongly agree"). The scale has a Cronbach's Alpha of 0.85 (Tayran & Ulupınar, 2011), which was 0.86 (pretest) and 0.78 (posttest) in the present study. There was no significant difference in pretest SCIP scores between the experimental and control groups. However, there was a significant difference in posttest SCIP scores between them. The experimental group had significantly higher posttest SCIP scores than pretest scores (p=0.00). It had significantly higher follow-up SCIP scores than posttest and pretest scores. There was no significant difference between the control group's pretest, posttest, and follow-up SCIP scores |
2 months
|
|
The following are quotations from the experimental group participants about digital storytelling.
Aikaikkuna: 2 months
|
The Questionnaire of Students' Opinions on Digital Storytelling (QSODS) consisted of three open-ended questions on (1) the contribution of digital storytelling to learning, (2) the effect of digital storytelling on students' compliance with isolation precautions and knowledge levels, and (3) students' opinions about digital storytelling. The following are quotations from the experimental group participants about digital storytelling. "I realized that I had some gaps in my knowledge of isolation methods and protective measures. It [digital storytelling] helped me fill those gaps." [Student (S). 10]. I think that it's [digital storytelling] fun and instructive. I helped me go over what I already knew and learn new stuff (S.12). We've had distance learning for a long time, so this storytelling thing helped me feel like I was in it" (S. 54). |
2 months
|
Yhteistyökumppanit ja tutkijat
Sponsori
Tutkijat
- Opintojen puheenjohtaja: Emel Gulnar, PhD, Kırıkkale University
- Opintojen puheenjohtaja: Nurcan Caliskan, PhD, Gazi University
- Opintojen puheenjohtaja: Cigdem Torun Kılıc, Msc, Karadeniz Teknik University
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Todellinen)
Opintojen valmistuminen (Todellinen)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muut tutkimustunnusnumerot
- KaradenizTU-1
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .